IP Library › Assignment 026002/0790
Patent Assignment
Reel/Frame 026002/0790

Assignment of Assignor's Interest

Recorded: 2011-03-23 Pages: 7
Assignor
NOVARTIS AG
Executed: 2011-03-17
Assignee
NOVARTIS PHARMACEUTICALS CORPORATION
ONE HEALTH PLAZA, EAST HANOVER, NEW JERSEY, 07936
Covered Properties (43)
At-1 Receptor Antagonists for Preventing and Treating Postischemic Renal Failure and for Protecting Ischemic Kidneys
Patent: 6,071,931 →
Application: 09/051,345 →
AT1 Receptor Antagonist for the Stimulation of Apoptosis
Patent: 6,174,910 →
Application: 09/142,003 →
Solid Oral Dosage Forms of Valsartan
Patent: 6,294,197 →
Application: 09/202,805 →
Method for Reducing Pericardial Fibrosis and Adhesion Formation
Patent: 6,211,217 →
Application: 09/270,412 →
Method of Treatment and Pharmaceutical Composition
Patent: 6,204,281 →
Application: 09/349,654 →
Additional Therapeutic Use
Patent: 6,465,502 →
Application: 09/468,663 →
Method of Treatment and Pharmaceutical Composition
Patent: 6,395,728 →
Application: 09/757,413 →
Publication: US 2001/0049384
Solid Oral Dosage Forms of Valsartan
Patent: 6,485,745 →
Application: 09/920,159 →
Additional therapeutic use
Application: 10/072,516 →
Publication: US 2002/0155986
Solid Oral Dosage Forms of Valsartan
Patent: 6,858,228 →
Application: 10/251,009 →
Publication: US 2003/0035832
Methods of Treatment and Pharmaceutical Composition
Patent: 7,468,390 →
Application: 10/341,868 →
Publication: US 2003/0144215
Crystalline Salt Forms of Valsartan
Patent: 6,869,970 →
Application: 10/353,389 →
Publication: US 2003/0171414
Process for the Preparation of Tetrazole Derivatives from Organo Boron and Organo Aluminium Azides
Patent: 7,943,647 →
Application: 10/564,337 →
Publication: US 2007/0043098
Coupling Reactions Useful in the Preparation of (1H-Tetrazol-5-Yl) Biphenyl Derivatives
Patent: 7,700,784 →
Application: 10/588,169 →
Publication: US 2007/0129413
New Salt Hydrates
Patent: 8,058,301 →
Application: 11/013,111 →
Publication: US 2005/0101652
Solid oral dosage forms of valsartan
Application: 11/208,131 →
Ophthalmic devices for sustained delivery of active compounds
Patent: 9,804,295 →
Application: 11/416,260 →
Publication: US 2006/0251696
Pharmaceutical Compositions of an AT1-Receptor Antagonist and an Insulin Secretion Enhancer
Patent: 7,687,528 →
Application: 11/508,353 →
Publication: US 2006/0281790
Compounds Containing S-N-valeryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester Moieties and Cations
Patent: 8,877,938 →
Application: 11/722,360 →
Publication: US 2009/0156585
Solid Dosage Forms of Valsartan, Amlodipine and Hydrochlorothiazide and Method of Making the Same
Application: 11/915,096 →
Publication: US 2010/0003321
Metal Salts of 2' - (1H-Tetrazol-5YL) -1. 1'-Biphenyl-4-Carboxaldehyde
Patent: 7,728,024 →
Application: 11/995,240 →
Publication: US 2008/0234490
Methods of Treatment and Pharmaceutical Composition
Patent: 8,101,659 →
Application: 12/147,570 →
Publication: US 2008/0262059
Macrocyclic Compounds Useful as Bace Inhibitors
Patent: 8,039,455 →
Application: 12/159,742 →
Publication: US 2009/0029960
Valsartan Salts
Patent: 8,278,339 →
Application: 12/186,172 →
Publication: US 2008/0293791
Pharmaceutical Composition Comprising a Renin Inhibitor, a Calcium Channel Blocker and a Diuretic
Patent: 8,183,295 →
Application: 12/188,604 →
Publication: US 2008/0300238
Additional Therapeutic Use
Application: 12/237,439 →
Publication: US 2010/0120877
Pharmaceutical Composition Containing Antihypertensive Agents
Patent: 8,101,599 →
Application: 12/338,066 →
Publication: US 2009/0099241
Pharmaceutical Composition Comprising Valsartan
Application: 12/341,669 →
Publication: US 2009/0105322
Use of Valsartan or Its Metabolite to in Hibit Platelet Aggregation
Application: 12/363,926 →
Publication: US 2010/0048654
Extended Release Gastro-Retentive Oral Drug Delivery System for Valsartan
Application: 12/377,949 →
Publication: US 2010/0233253
Process for Preparing Biaryl Substituted 4-Amino-Butyric Acid or Derivatives Thereof and Their Use in the Production of Nep Inhibitors
Application: 12/438,798 →
Publication: US 2009/0326066
Microemulsion Dosage Forms of Valsartan and Methods of Making the Same
Application: 12/517,105 →
Publication: US 2010/0035949
Process for Preparing 5-Biphenyl-4-Amino-2-Methyl Pentanoic Acid
Patent: 8,115,016 →
Application: 12/522,767 →
Publication: US 2010/0113801
Pharmaceutical Formulation of Valsartan
Application: 12/681,657 →
Publication: US 2010/0222334
Combination of Organic Compounds Useful for Treating Diabetes
Patent: 8,106,081 →
Application: 12/705,655 →
Publication: US 2010/0144811
Coupling Reactions Useful in the Preparation of (1H-Tetrazol-5-Yl) Biphenyl Derivatives
Application: 12/715,477 →
Publication: US 2010/0152458
Dual-Acting Pharmaceutical Compositions Based on Superstructures of Angiotensin Receptor Antagonist/Blocker (Arb) and Neutral Endopeptidase (Nep) Inhibitor
Application: 12/741,251 →
Publication: US 2010/0267786
New Combinations
Application: 12/764,571 →
Publication: US 2010/0204190
Process for the Manufacture of Valsartan
Application: 12/815,704 →
Publication: US 2010/0249429
Tablet Formulations Comprising Valsartan
Application: 12/828,751 →
Publication: US 2010/0267789
Solid Dosage Forms of Valsartan and Amlodipine and Method of Making the Same
Application: 12/852,542 →
Publication: US 2010/0303906
New Processes
Patent: 8,580,974 →
Application: 12/863,213 →
Publication: US 2011/0046397
Valsartan Solid Oral Dosage Forms and Methods of Making Such Formulations
Application: 12/919,165 →
Publication: US 2011/0028526
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 7, 2000
From: HUMKE, ULRICH
To: NOVARTIS AG
Reel/Frame 010649/0447 →
Assignment of Assignor's Interest Sep 25, 2000
From: GASPARO, MARC DE; BULLOCK, GILLIAN ROSEMARY; CRISCIONE, LEOLUCA
To: NOVARTIS AG
Reel/Frame 011179/0760 →
Assignment of Assignor's Interest Nov 13, 2000
From: SPINALE, FRANCIS G.; GASPARO, MARC DE
To: NOVARTIS AG
Reel/Frame 011286/0084 →
Assignment of Assignor's Interest Jan 16, 2001
From: WEBB, RANDY LEE; GASPARO, MARC DE
To: NOVARTIS AG
Reel/Frame 011507/0146 →
Assignment of Assignor's Interest Jul 30, 2001
From: WAGNER, ROBERT FRANK; KATAKUSE, YOSHIMITSU; TAIKE, TAKASHI; YAMATO, FUJIKI
To: NOVARTIS AG
Reel/Frame 012033/0120 →
Assignment of Assignor's Interest Jan 18, 2002
From: BULLOCK, GILLIAN ROSEMARY; DE GASPARO, MARC; GANTER, SABINA MARIA
To: NOVARTIS AG
Reel/Frame 012525/0764 →
Assignment of Assignor's Interest Sep 8, 2004
From: MARTI, ERWIN ERNST
To: NOVARTIS AG
Reel/Frame 015767/0668 →
Assignment of Assignor's Interest Jan 15, 2008
From: FENG, LILI; GODTFREDSEN, SVEN ERIK; KARPINSKI, PIOTR; SUTTON, PAUL ALLEN
To: NOVARTIS AG
Reel/Frame 020365/0386 →
Assignment of Assignor's Interest Jun 4, 2008
From: KSANDER, GARY MICHAEL; WEBB, RANDY LEE
To: NOVARTIS AG
Reel/Frame 021038/0682 →
Assignment of Assignor's Interest Jun 29, 2009
From: WINTERTON, LYNN COOK; LALLY, JOHN MARTIN
To: NOVARTIS AG
Reel/Frame 022888/0163 →
Assignment of Assignor's Interest Oct 22, 2009
From: SEDELMEIER, GOTTFRIED
To: NOVARTIS AG
Reel/Frame 023408/0317 →
Assignment of Assignor's Interest Oct 22, 2009
From: SEDELMEIER, GERHARD; GRIMLER, DOMINIQUE
To: NOVARTIS AG
Reel/Frame 023408/0635 →
Assignment of Assignor's Interest Jan 25, 2010
From: KRELL, CHRISTOPH; HIRT, HANS
To: NOVARTIS AG
Reel/Frame 023840/0991 →
Assignment of Assignor's Interest Sep 24, 2010
From: CAO, YU; JOSHI, YATINDRA; LI, PING; PUDIPEDDI, MADHUSUDHAN
To: NOVARTIS AG
Reel/Frame 025042/0520 →
Assignment of Assignor's Interest Jul 17, 2017
From: NOVARTIS PHARAMACEUTICALS CORPORATION
To: NOVARTIS AG
Reel/Frame 043021/0386 →
Confirmatory Deed of Assignment Effective April 8, 2019 Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →